Venture Fund Member Profile
|
 |
 |
BR Venture Fund (BRV) is Johnson’s early stage venture capital fund. Operated entirely by a team of MBA students, BRV typically invests up to $250,000 in US-based high growth companies across all industries. Initially funded by donations to the University, BRV is a true evergreen fund, recycling all proceeds for reinvestment. Along with investing startup capital in promising new companies, BRV also serves as the gateway to Cornell technologies by providing its investment partners unique access to new innovations. Through its established relationships with other investors, BRV has the ability to create new syndicate opportunities as well as participate in those presented to the fund.
An investment from BRV not only brings with it the backing of one of the top Business Schools in the world, but also the ability to leverage any of Cornell’s many resources.
 |
Aaron Holiday
COO and Fund Manager
BR Venture Fund |
After successfully starting and running a software consulting firm for two years as a student at Morehouse College, Aaron began his professional career at Goldman Sachs in 2004. At Goldman Aaron supported the Program Trading desk. In 2008, Aaron joined the head of Product Development at GFI Group to redesign the firm’s Foreign Exchange Options trading technology platform. While in New York City, Aaron served on three boards: iMentor, Harlem Independent Living Center (HILC), and DSJ Co-op Board of directors.
At Cornell, Aaron leads the eLab, an incubator that accelerates 9 start-ups. Aaron is also a member of the Entrepreneurship@Cornell student board of directors and leads an initiative to launch a university wide mobile application that uses location based technology to connect Cornell’s community of alumni, students, and faculty. During the 2010 winter break, Aaron developed an access to venture capital strategy and wrote a white paper on investing in biopharmaceutical startups for Ezra Pharmaceuticals, a start-up that leverages intellectual property from Weill Cornell Medical School. The work for Ezra was an effort to help the start-up raise $10M in Series A financing. During the 2011 spring break, Aaron led a team of 7 MBAs in the New Orleans IdeaVillage competition where his team created a sales pipeline and gained access to distribution in Asia for a local entrepreneur who manufactured high-end spa equipment. This summer, Aaron will be working for a NYC venture capital backed start-up. Aaron is a MLT Fellow and a Consortium for Graduate Study in Management Fellow.
Representative Investments
 |
Adenios technology both raises and lowers the permeability of the blood brain barrier to precisely control the delivery of existing drugs. The technology, spun out of Cornell University, can be paired with unmodified current therapeutics to either improve or block delivery of multiple compounds into the brain. |
 |
e2e Materials , based in Ithaca, NY develops, designs, engineers and produces proprietary biocomposites for the furniture, cabinetry and other markets. e2e’s proprietary composites are made from soy flour and natural grass fiber such as jute, flax and kenaf. Products made from e2e’s biocomposite are stronger, lighter, safer and cheaper than those made from formaldehyde-laden wood composites. Additionally, e2e uses only a small fraction of the energy required for wood composites, saving billions of pounds of CO2. |
 |
GNS Healthcare is a healthcare IT company that applies machine learning and simulation technology to optimize patient treatment in partnership with health insurance companies, pharmacy benefit managers, and pharmaceutical & biotech companies. GNS Healthcare is the information guru between drug makers and drug buyers matching drugs to patients to deliver on the promise of “smart” medicine. |
 |
NovaSterilis is committed to providing a new level of patient safety and product performance through the development of a new, emerging technology. The development of the supercritical carbon dioxide as a solvent for the NovaKill sterilent allows the biomedical community to achieve sterilization without compromising the product’s integrity. |
Aaron participated in the FundingPost event: NYC Winter VC & Angel Event
on Tuesday, December 6, 2011 in NY, Sponsored by WeiserMazars
To list your Company on our website and make your profile available to Aaron and 7,500+ other VCs and Angel Investors, Click Here.
============================================
About FundingPost
For over Twelve Years FundingPost has worked with thousands
of Angel and Venture Capital Investors. We believe that it is
important to reach investors in every medium possible -
both online and offline. We have been directly responsible for
tons of success stories and Millions and Millions of dollars raised.
We look forward to introducing your company to the leading Venture and Angel Investors nationwide.
============================================
|
| Venture Fund Member Profile |
|
Bookmark to del.icio.us
Tweet this Profile
